<DOC>
	<DOCNO>NCT02864264</DOCNO>
	<brief_summary>The primary purpose study determine single multiple dos BMS-986184 safe well tolerate healthy male female subject . The primary purpose proof mechanism study determine safety efficacy patient ulcerative colitis .</brief_summary>
	<brief_title>Single Ascending Dose Multiple Ascending Dose Study Healthy Participants Proof Mechanism Study Patients With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>For information regard BristolMyers Squibb Clinical Trial participation , please visit www.BMSStudyConnect.com Female subject must provide documentation acceptable method surgical sterilization meet protocol criterion menopause Male female healthy participant , determine evidence organ dysfunction clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory procedure determination beyond consistent target population . Any bacterial , fungal viral infection , include tuberculosis , HIV , hepatitis B hepatitis C Subjects history type heart disease , heart irregularity , high blood pressure , low blood pressure , fainting , ECG abnormality , heart disease childhood Other protocol define inclusion/exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>